Family history and DNA analysis in patients with suspected Huntington's disease - PubMed (original) (raw)
Family history and DNA analysis in patients with suspected Huntington's disease
S Siesling et al. J Neurol Neurosurg Psychiatry. 2000 Jul.
Abstract
Objectives: Until recently a definite diagnosis of Huntington's disease could be made by a combination of clinical findings, a positive family history, and pathological confirmation. Prevalence data are based on these criteria. After finding the gene and its pathogenic mutation direct diagnostic confirmation became available. The aim of this study was to determine to what extent the direct assessment of CAG repeat length has allowed the diagnoses of additional patients, with atypical psychiatric or neurological disease, or those without a family history, that could otherwise not be diagnosed using traditional criteria.
Patients and methods: From all 191 referred patients suspected of having Huntington's disease between July 1993 and January 1996 CAG repeat length was determined and the family history was reviewed in the Leiden roster. After a retrospective search the patients were subdivided in positive, negative, suspect, and unknown family histories. Patients with an expanded repeat (>35) were finally diagnosed as having Huntington's disease. The family history was compared with the repeat length and the clinical features.
Results: Clinical information was obtained for 172 patients. Of these, 126 patients had an expanded repeat, 77 had a positive, eight a negative, 40 a suspect, and one an unknown family history. Of the 44 patients with a normal repeat length four had a positive family history. Of the two patients with an intermediate repeat (between 30-36 repeats), one with a negative family history received a clinical diagnosis of Gilles de la Tourette's syndrome. The other had an unknown family history.
Conclusion: Despite verification of the family history through the Leiden roster, many more patients and families could be diagnosed with the new approach than would have been possible with the traditional criteria. Because prevalence studies have been based on this type of information, the data suggest an underestimation of the prevalence of Huntington's disease in the community of 14%.
Similar articles
- Neuropathological diagnosis and CAG repeat expansion in Huntington's disease.
Xuereb JH, MacMillan JC, Snell R, Davies P, Harper PS. Xuereb JH, et al. J Neurol Neurosurg Psychiatry. 1996 Jan;60(1):78-81. doi: 10.1136/jnnp.60.1.78. J Neurol Neurosurg Psychiatry. 1996. PMID: 8558157 Free PMC article. - Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.
Zappacosta B, Monza D, Meoni C, Austoni L, Soliveri P, Gellera C, Alberti R, Mantero M, Penati G, Caraceni T, Girotti F. Zappacosta B, et al. Arch Neurol. 1996 Jun;53(6):493-7. doi: 10.1001/archneur.1996.00550060035012. Arch Neurol. 1996. PMID: 8660149 - Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing.
Ramos-Arroyo MA, Moreno S, Valiente A. Ramos-Arroyo MA, et al. J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):337-42. doi: 10.1136/jnnp.2004.036806. J Neurol Neurosurg Psychiatry. 2005. PMID: 15716522 Free PMC article. - Tics as an initial manifestation of juvenile Huntington's disease: case report and literature review.
Cui SS, Ren RJ, Wang Y, Wang G, Chen SD. Cui SS, et al. BMC Neurol. 2017 Aug 8;17(1):152. doi: 10.1186/s12883-017-0923-1. BMC Neurol. 2017. PMID: 28789621 Free PMC article. Review. - Exploring the correlates of intermediate CAG repeats in Huntington disease.
Ha AD, Jankovic J. Ha AD, et al. Postgrad Med. 2011 Sep;123(5):116-21. doi: 10.3810/pgm.2011.09.2466. Postgrad Med. 2011. PMID: 21904093 Review.
Cited by
- HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.
Warby SC, Visscher H, Collins JA, Doty CN, Carter C, Butland SL, Hayden AR, Kanazawa I, Ross CJ, Hayden MR. Warby SC, et al. Eur J Hum Genet. 2011 May;19(5):561-6. doi: 10.1038/ejhg.2010.229. Epub 2011 Jan 19. Eur J Hum Genet. 2011. PMID: 21248742 Free PMC article. - Neuronal intranuclear and neuropil inclusions for pathological assessment of Huntington's disease.
Maat-Schieman M, Roos R, Losekoot M, Dorsman J, Welling-Graafland C, Hegeman-Kleinn I, Broeyer F, Breuning M, van Duinen S. Maat-Schieman M, et al. Brain Pathol. 2007 Jan;17(1):31-7. doi: 10.1111/j.1750-3639.2006.00040.x. Brain Pathol. 2007. PMID: 17493035 Free PMC article. - Long-term monitoring of the mortality trend of Huntington's disease in Austria.
Ekestern E, Lebhart G. Ekestern E, et al. Eur J Epidemiol. 2005;20(2):169-72. doi: 10.1007/s10654-004-4658-0. Eur J Epidemiol. 2005. PMID: 15792284 - Clinical and genetic investigation of a Brazilian family with Huntington's disease.
Agostinho LA, Spitz M, Pereira JS, Paiva CL. Agostinho LA, et al. Funct Neurol. 2016 Jul-Sep;31(3):135-42. doi: 10.11138/fneur/2016.31.3.135. Funct Neurol. 2016. PMID: 27678206 Free PMC article.
References
- Am J Hum Genet. 1983 Mar;35(2):241-62 - PubMed
- J Neurol Neurosurg Psychiatry. 1996 Dec;61(6):625-7 - PubMed
- J Med Genet. 1991 Aug;28(8):515-9 - PubMed
- Nat Genet. 1993 Aug;4(4):387-92 - PubMed
- Nat Genet. 1993 Aug;4(4):393-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical